SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-21-042200
Filing Date
2021-02-16
Accepted
2021-02-12 21:33:28
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G d132566dsc13g.htm SC 13G 36858
  Complete submission text file 0001193125-21-042200.txt   38243
Mailing Address 5858 HORTON STREET #455 EMERYVILLE CA 94608
Business Address 5858 HORTON STREET #455 EMERYVILLE CA 94608 5105052680
4D Molecular Therapeutics Inc. (Subject) CIK: 0001650648 (see all company filings)

IRS No.: 473506994 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91921 | Film No.: 21631575
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O 4D MOLECULAR THERAPEUTICS INC. 5858 HORTON STREET #455 EMERYVILLE CA 94608
Business Address
Kirn David (Filed by) CIK: 0001834021 (see all company filings)

Type: SC 13G